Diametric Capital, LP Eton Pharmaceuticals, Inc. Transaction History

Diametric Capital, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$5.71 - $8.85 $282,850 - $438,393	-49,536 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$6.93 - $10.07 $14,532 - $21,116	-2,097 Reduced 4.06%	49,536 $363,000
Q4 2020 Feb 16, 2021	BUY	$6.65 - $8.83 $136,218 - $180,873	20,484 Added 65.76%	51,633 $420,000
Q3 2020 Nov 13, 2020	SELL	$4.96 - $9.06 $985,403 - $1.8 Million	-198,670 Reduced 86.45%	31,149 $246,000
Q2 2020 Aug 14, 2020	SELL	$3.5 - $6.09 $777,994 - $1.35 Million	-222,284 Reduced 49.17%	229,819 $1.25 Million
Q1 2020 May 15, 2020	BUY	$2.87 - $7.47 $1.3 Million - $3.38 Million	452,103 New	452,103 $1.85 Million
Q4 2019 Feb 14, 2020	SELL	$5.59 - $7.2 $911,354 - $1.17 Million	-163,033 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$5.19 - $8.72 $96,222 - $161,668	18,540 Added 12.83%	163,033 $1.03 Million
Q2 2019 Aug 14, 2019	BUY	$7.1 - $8.39 $160,602 - $189,781	22,620 Added 18.56%	144,493 $1.14 Million
Q1 2019 May 15, 2019	BUY	$5.72 - $8.0 $359,622 - $502,968	62,871 Added 106.56%	121,873 $975,000
Q4 2018 Feb 14, 2019	BUY	$5.79 - $6.68 $341,621 - $394,133	59,002 New	59,002 $361,000

9.44M

261K

500

Ticker ETON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,297,000
Market Cap $333M
Description
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...

Get notified when there are updates to the investment portfolio of Diametric Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Diametric Capital, LP with notifications on news.